Preoperative immunotherapy for mesothelioma shows favorable outcomes

by Dipali Pathak,Baylor College of MedicineCredit: Pixabay/CC0 Public DomainIn a study published recently in the journalClinical Cancer Research, researchers at Baylor College of Medicine

Updated on: January 04,2024 12

Preoperative immunotherapy for mesothelioma shows favorable outcomes

by Dipali Pathak,Baylor College of MedicineCredit: Pixabay/CC0 Public DomainIn a study published recently in the journalClinical Cancer Research, researchers at Baylor College of Medicine

Updated on:January 04,2024 12

Endometrial cancer: New insights into a deadly disparity

byMemorial Sloan Kettering Cancer CenterCredit: Pixabay/CC0 Public DomainEndometrial cancer—which develops in the lining of the uterus (womb) and is sometimes called uterine cancer—is on the ris

Updated on: December 28,2023 6

Endometrial cancer: New insights into a deadly disparity

byMemorial Sloan Kettering Cancer CenterCredit: Pixabay/CC0 Public DomainEndometrial cancer—which develops in the lining of the uterus (womb) and is sometimes called uterine cancer—is on the ris

Updated on:December 28,2023 6

Magrolimab plus azacitidine results in promising activity in higher-risk MDS patients

byH. Lee Moffitt Cancer Center & Research InstituteHemoglobin changes from baseline over time on treatment with magrolimab + azacitidine in patients with HR-MDS (N = 95). Data shown are medi

Updated on: December 28,2023 9

Magrolimab plus azacitidine results in promising activity in higher-risk MDS patients

byH. Lee Moffitt Cancer Center & Research InstituteHemoglobin changes from baseline over time on treatment with magrolimab + azacitidine in patients with HR-MDS (N = 95). Data shown are medi

Updated on:December 28,2023 9

Extreme phenotype approach identifies rare ATR variants as potential male breast cancer susceptibility alleles

by Impact Journals LLCImpact of splicing variants. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28358In oncogenetics, some patients could be considered as "extreme phenotypes,&qu

Updated on: December 25,2023 10

Extreme phenotype approach identifies rare ATR variants as potential male breast cancer susceptibility alleles

by Impact Journals LLCImpact of splicing variants. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28358In oncogenetics, some patients could be considered as "extreme phenotypes,&qu

Updated on:December 25,2023 10

Study shows clinical benefit of a new way of treating advanced ER+ breast cancer

by University of LiverpoolCredit: Unsplash/CC0 Public DomainA research paper published today inThe Lancet Oncologydemonstrates that the drug enobosarm, a selective androgen receptor m

Updated on: May 26,2024 3

Study shows clinical benefit of a new way of treating advanced ER+ breast cancer

by University of LiverpoolCredit: Unsplash/CC0 Public DomainA research paper published today inThe Lancet Oncologydemonstrates that the drug enobosarm, a selective androgen receptor m

Updated on:May 26,2024 3

Severe mental illness linked to low attendance at cancer screening

byUniversity of SurreyCredit: CC0 Public DomainPeople with severe mental illness are less likely to attend cancer screening compared to those who do not have such conditions, according to new re

Updated on: January 22,2024 15

Severe mental illness linked to low attendance at cancer screening

byUniversity of SurreyCredit: CC0 Public DomainPeople with severe mental illness are less likely to attend cancer screening compared to those who do not have such conditions, according to new re

Updated on:January 22,2024 15

Surgery first for colon cancer? Not so fast, according to new study

by National Comprehensive Cancer NetworkRadiologic response, TRG, and clinical T stage. (A) Radiologic response among patients with different clinical T stage; patients with cT2–3 disease were more li

Updated on: January 10,2024 9

Surgery first for colon cancer? Not so fast, according to new study

by National Comprehensive Cancer NetworkRadiologic response, TRG, and clinical T stage. (A) Radiologic response among patients with different clinical T stage; patients with cT2–3 disease were more li

Updated on:January 10,2024 9

Patient-derived Organoids: Revolutionizing Cancer Research and Treatment

Updated on: November 14,2024 0

Patient-derived Organoids: Revolutionizing Cancer Research and Treatment

Updated on:November 14,2024 0

Guideline updated for initial management of advanced prostate cancer

by Elana GotkineFor patients with noncastrate advanced prostate cancer, docetaxel, abiraterone, enzalutamide, apalutamide, or darolutamide are each recommended as standards of care with androgen depri

Updated on: January 08,2024 10

Guideline updated for initial management of advanced prostate cancer

by Elana GotkineFor patients with noncastrate advanced prostate cancer, docetaxel, abiraterone, enzalutamide, apalutamide, or darolutamide are each recommended as standards of care with androgen depri

Updated on:January 08,2024 10

Avelumab plus axitinib significantly improve progression-free survival in untreated renal cell carcinoma

byEuropean Society for Medical OncologyCredit: CC0 Public DomainA combination of the immune checkpoint blocker, avelumab, plus the tyrosine kinase inhibitor (TKI), axitinib, significantly improv

Updated on: December 18,2023 19

Avelumab plus axitinib significantly improve progression-free survival in untreated renal cell carcinoma

byEuropean Society for Medical OncologyCredit: CC0 Public DomainA combination of the immune checkpoint blocker, avelumab, plus the tyrosine kinase inhibitor (TKI), axitinib, significantly improv

Updated on:December 18,2023 19

New AI model detects 90% of lymphatic cancer cases

by Chalmers University of TechnologyCredit:The Lancet Digital Health(2023). DOI: 10.1016/S2589-7500(23)00203-0Medical image analysis using AI has developed rapidly in recent years. No

Updated on: March 20,2024 20

New AI model detects 90% of lymphatic cancer cases

by Chalmers University of TechnologyCredit:The Lancet Digital Health(2023). DOI: 10.1016/S2589-7500(23)00203-0Medical image analysis using AI has developed rapidly in recent years. No

Updated on:March 20,2024 20

Machine learning to identify cancer type-specific driver mutations for the development of new drug targets

by Pohang University of Science & Technology (POSTECH)Credit: POSTECHAccording to Statistics Korea, cancer is the top cause of death in 2021, accounting for 26% of deaths. Most cancer patients mis

Updated on: December 25,2023 8

Machine learning to identify cancer type-specific driver mutations for the development of new drug targets

by Pohang University of Science & Technology (POSTECH)Credit: POSTECHAccording to Statistics Korea, cancer is the top cause of death in 2021, accounting for 26% of deaths. Most cancer patients mis

Updated on:December 25,2023 8